DocDollars

Vifor Pharma, Inc.

PA · United States · Reporting entity ID 100000151638

Total reported 2019–2025
$7.85M
#569 of 2,960 reporting companies — 0% of all reported industry payments
$6.94M in general payments across 89,773 records, plus $913K in research funding across 197 records.

How it breaks down

General payments $6,937,511
Research funding $912,637

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Vifor Pharma, Inc. reported $7.85M to US doctors and teaching hospitals from 2019 to 2025, ranking #569 of 2,960 reporting companies. 12% of that was research funding and 88% general payments such as consulting, speaking, food and travel. 89,773 general payment records and 197 research records were filed.

Common questions about Vifor Pharma, Inc.

How much has Vifor Pharma, Inc. paid US doctors?

Vifor Pharma, Inc. reported $7,850,148 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,937,511 in general payments, $912,637 in research funding.

How does Vifor Pharma, Inc. rank among drug and device companies?

It ranks #569 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Vifor Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.